News
The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern over the use of unapproved GLP-1 receptor agonists for weight loss, such as ...
31m
Asianet Newsable on MSNTexas Sues Eli Lilly Over Bribery Allegations: Retail Focuses On Company’s Upbeat PerformanceTexas Attorney General Ken Paxton alleged that Lilly offered illegal incentives to medical providers in Texas designed to ...
Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its ...
Eli Lilly and Company faces valuation pressure after disappointing Orforglipron results. Discover why now isn't the time to ...
Texas Attorney General Ken Paxton has filed a lawsuit against Eli Lilly, alleging the pharmaceutical giant engaged in bribery ...
Texas Attorney General Ken Paxton has filed a lawsuit against pharmaceutical giant Eli Lilly, accusing the company of bribing medical providers to prescribe its lucrative medications. The lawsuit ...
Eli Lilly (LLY) stock in focus as Texas sues the company for alleged bribery related to weight loss drugs like Zepbound and ...
Its shares aren't exactly cheap at recent levels, though.
A UK government and Eli Lilly £85 million program will expand obesity care nationwide, offering digital, community, and ...
Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.
Growth investing can seem deceptively simple on the surface. In a nutshell, it involves identifying a company growing faster than the rest of the market, then betting that someone else will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results